James Scallan
Comment & OpinionM&A activity in plant-based is soaring, with huge price tags to match
We believe investors will continue to pay high valuations for the right plant-based assets until the landscape is more consolidated, says James Scallan, consumer, food & retail group MD at Houlihan Lokey